Page last updated: 2024-08-21

oxazoles and Anemia

oxazoles has been researched along with Anemia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adelman, DC; Bible, K; Heath, EI; Lorusso, PM; Martell, RE	1
Arrobas, M; Caravaca, F; Cid, MC; Cubero, J; López-Minguez, JR; Miranda, MP; Pizarro, JL; Sanchez-Casado, E	1

Trials

2 trial(s) available for oxazoles and Anemia

Article	Year
A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors. Investigational new drugs, 2008, Volume: 26, Issue:1 Topics: Administration, Oral; Adult; Aged; Anemia; Angiogenesis Inhibitors; Area Under Curve; Biological Availability; CDC2-CDC28 Kinases; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neutropenia; Oxazoles; Radiotherapy, Adjuvant; Thiazoles; Time Factors; Treatment Outcome	2008
Haemodynamic changes induced by the correction of anaemia by erythropoietin: role of antiplatelet therapy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1995, Volume: 10, Issue:9 Topics: Adult; Aged; Anemia; Aspirin; Dipyridamole; Erythropoietin; Female; Hemodynamics; Humans; Male; Middle Aged; Oxazoles; Platelet Aggregation Inhibitors; Prospective Studies; Recombinant Proteins; Renal Dialysis; Ticlopidine; Time Factors; Uremia	1995

Article

Year

A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors.

Investigational new drugs, 2008, Volume: 26, Issue:1

Topics: Administration, Oral; Adult; Aged; Anemia; Angiogenesis Inhibitors; Area Under Curve; Biological Availability; CDC2-CDC28 Kinases; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neutropenia; Oxazoles; Radiotherapy, Adjuvant; Thiazoles; Time Factors; Treatment Outcome

2008

Haemodynamic changes induced by the correction of anaemia by erythropoietin: role of antiplatelet therapy.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1995, Volume: 10, Issue:9

Topics: Adult; Aged; Anemia; Aspirin; Dipyridamole; Erythropoietin; Female; Hemodynamics; Humans; Male; Middle Aged; Oxazoles; Platelet Aggregation Inhibitors; Prospective Studies; Recombinant Proteins; Renal Dialysis; Ticlopidine; Time Factors; Uremia

1995